Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MT › Cut Bank › NPI 1831143080
Hospital

Northern Rockies Medical Center, INC.

Northern Rockies Medical Center, INC. was paid $543K by Medicaid between Jan 2018 and Dec 2024, across 71 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 60% of everything it billed.

33Billing provider infoNORTHERN ROCKIES MEDICAL CENTER, INC.
CUT BANK, MT 59427
33aNPI1831143080assigned 05/20/2006
33bProvider typeCritical Access Hospital
28Total paid$543K
24GClaims76,791
24DCodes billed71
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Montana

Rank by total paid#10 of 25
Median peer was paid$185K
This provider vs. median2.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201812,022$83K
201911,924$78K
202010,652$62K
202110,699$69K
202211,678$84K
202311,656$94K
2024incomplete8,160$72K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99282 Emergency department visit for the evaluation and management, low to moderate severity 60% 13,026 11,909 $324K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 22% 3,855 3,419 $121K
99281 Emergency department visit for the evaluation and management, self-limited or minor 3.9% 4,222 3,894 $21K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.4% 4,390 1,257 $13K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 1.5% 953 762 $8K
70450 Computed tomography, head or brain; without contrast material 1.2% 171 153 $6K
80053 Comprehensive metabolic panel 1.0% 6,658 5,924 $6K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life <1% 138 108 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 964 491 $3K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 4,017 3,643 $3K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 61 42 $3K
85027 <1% 3,601 3,184 $3K
59 more codes
36415 Collection of venous blood by venipuncture <1% 6,971 $2K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 1,798 $2K
71046 Radiologic examination, chest; 2 views <1% 595 $2K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,067 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 609 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 831 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 983 $2K
81001 <1% 2,974 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 263 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,129 $1K
J7030 Infusion, normal saline solution , 1000 cc <1% 1,424 $875.04
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 801 $711.51
84443 Thyroid stimulating hormone (TSH) <1% 2,539 $607.40
80048 Basic metabolic panel (calcium, ionized) <1% 471 $557.49
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 564 $541.24
83036 Hemoglobin; glycosylated (A1C) <1% 1,059 $504.85
85651 <1% 262 $493.61
87081 <1% 159 $485.46
84439 <1% 575 $397.13
73610 <1% 14 $250.16
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 1,495 $247.36
71045 Radiologic examination, chest; single view <1% 225 $235.80
73030 <1% 13 $234.32
97161 <1% 100 $209.40
87420 <1% 88 $180.90
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,036 $170.95
81025 <1% 462 $106.64
84484 <1% 409 $105.30
86140 <1% 158 $101.84
82607 <1% 56 $100.18
80061 Lipid panel <1% 1,822 $98.10
83690 <1% 492 $77.40
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 403 $73.80
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 280 $68.39
83655 <1% 35 $46.80
87186 <1% 12 $41.88
85018 <1% 35 $40.50
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 286 $35.10
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 271 $0.00
77063 Screening digital breast tomosynthesis, bilateral 0% 32 $0.00
83735 0% 14 $0.00
83605 0% 38 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 188 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 35 $0.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 0% 42 $0.00
82150 0% 98 $0.00
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 0% 25 $0.00
97535 Self-care/home management training, each 15 minutes 0% 39 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 0% 13 $0.00
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 0% 32 $0.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 0% 24 $0.00
85610 0% 201 $0.00
86431 0% 43 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 0% 13 $0.00
73630 0% 13 $0.00
97530 Therapeutic activities, direct patient contact, each 15 minutes 0% 49 $0.00
82652 0% 23 $0.00
77067 Screening mammography, bilateral, including computer-aided detection 0% 32 $0.00
86038 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTAYLOR, CHERIE (PRESIDENT)
Same official

Other billing entities under TAYLOR, CHERIE

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.